Skip to main content
Top
Published in: Acta Diabetologica 11/2018

01-11-2018 | Original Article

Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study

Authors: G P Fadini, A Solini, M L Manca, G Zatti, I Karamouzis, A Di Benedetto, L Frittitta, A Avogaro, For the DARWIN-T2D Network

Published in: Acta Diabetologica | Issue 11/2018

Login to get access

Abstract

Aims

Type 2 diabetes (T2D) accelerates the decline in glomerular function; however, some individuals do not develop chronic kidney disease despite advanced age and long-lasting T2D. We aimed to phenotype patients with T2D aged 80 years or older who presented with a fully preserved kidney function.

Methods

From an Italian population of 281,217 T2D outpatients, we collected data on demographics, anthropometrics, diabetes duration, HbA1c, fasting plasma glucose, lipids, liver enzymes, estimated glomerular filtration rate (eGFR), albumin excretion rate (AER), chronic complications, and medication use. We primarily compared patients with a fully preserved kidney function (eGFR > 90 ml/min/1.73 m2 and AER < 30 mg/24 h, or G1A1) with those with mild kidney impairment (eGFR 60–90 ml/min/1.73 m2 and AER < 30 mg/24 h, or G2A1).

Results

N = 113,860 had available data for eGFR and AER, 21,648 of whom were aged ≥ 80. G1A1 (n = 278) and G2A1 (n = 6647) patients represented 1.3 and 30.7% of aged T2D patients, respectively, with an average diabetes duration of 16 years. Differences between the G1A1 and G2A1 groups were entered in a multiple logistic regression analysis with and without imputation of missing data. After adjustment and in both imputed and non-imputed datasets, younger age, lower BMI and lower triglycerides were associated with fully preserved versus mildly impaired kidney function. The comparison between G1A1 and G1A2/3 yielded different results.

Conclusions

In a rare population of patients with a fully preserved kidney function despite old age and long-lasting diabetes, lower BMI and triglycerides suggest that protection from lipotoxicity may preserve kidney function over time.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mazzola P, Rimoldi SM, Rossi P et al (2016) Aging in Italy: the need for new welfare strategies in an old country. Gerontologist 56:383–390CrossRef Mazzola P, Rimoldi SM, Rossi P et al (2016) Aging in Italy: the need for new welfare strategies in an old country. Gerontologist 56:383–390CrossRef
2.
go back to reference England K, Azzopardi-Muscat N (2017) Demographic trends and public health in Europe. Eur J Public Health 27:9–13CrossRef England K, Azzopardi-Muscat N (2017) Demographic trends and public health in Europe. Eur J Public Health 27:9–13CrossRef
3.
go back to reference Lopreite M, Mauro M (2017) The effects of population ageing on health care expenditure: a Bayesian VAR analysis using data from Italy. Health Policy 121:663–674CrossRef Lopreite M, Mauro M (2017) The effects of population ageing on health care expenditure: a Bayesian VAR analysis using data from Italy. Health Policy 121:663–674CrossRef
4.
go back to reference Vanholder R, Annemans L, Brown E et al (2017) Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13:393–409CrossRef Vanholder R, Annemans L, Brown E et al (2017) Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol 13:393–409CrossRef
5.
go back to reference Stevens LA, Li S, Wang C et al (2010) Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 55:S23–S33CrossRef Stevens LA, Li S, Wang C et al (2010) Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 55:S23–S33CrossRef
6.
go back to reference Tsai CW, Ting IW, Yeh HC, Kuo CC (2017) Longitudinal change in estimated GFR among CKD patients: a 10-year follow-up study of an integrated kidney disease care program in Taiwan. PLoS One 12:e0173843CrossRef Tsai CW, Ting IW, Yeh HC, Kuo CC (2017) Longitudinal change in estimated GFR among CKD patients: a 10-year follow-up study of an integrated kidney disease care program in Taiwan. PLoS One 12:e0173843CrossRef
7.
go back to reference Fox CS, Matsushita K, Woodward M et al (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380:1662–1673CrossRef Fox CS, Matsushita K, Woodward M et al (2012) Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis. Lancet 380:1662–1673CrossRef
8.
go back to reference Bruck K, Stel VS, Gambaro G et al (2016) CKD prevalence varies across the European general population. J Am Soc Nephrol 27:2135–2147CrossRef Bruck K, Stel VS, Gambaro G et al (2016) CKD prevalence varies across the European general population. J Am Soc Nephrol 27:2135–2147CrossRef
9.
go back to reference Pugliese G, Solini A, Bonora E et al (2014) Chronic kidney disease in type 2 diabetes: lessons from the renal insufficiency and cardiovascular events (RIACE) Italian Multicentre Study. Nutr Metab Cardiovasc Dis 24:815–822CrossRef Pugliese G, Solini A, Bonora E et al (2014) Chronic kidney disease in type 2 diabetes: lessons from the renal insufficiency and cardiovascular events (RIACE) Italian Multicentre Study. Nutr Metab Cardiovasc Dis 24:815–822CrossRef
10.
go back to reference Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98CrossRef Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14:88–98CrossRef
11.
go back to reference Canaud B, Tong L, Tentori F et al (2011) Clinical practices and outcomes in elderly hemodialysis patients: results from the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol 6:1651–1662CrossRef Canaud B, Tong L, Tentori F et al (2011) Clinical practices and outcomes in elderly hemodialysis patients: results from the dialysis outcomes and practice patterns study (DOPPS). Clin J Am Soc Nephrol 6:1651–1662CrossRef
12.
go back to reference Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef Kurella Tamura M, Covinsky KE, Chertow GM, Yaffe K, Landefeld CS, McCulloch CE (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef
13.
go back to reference Thomas B, Matsushita K, Abate KH et al (2017) Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol 28:2167–2179CrossRef Thomas B, Matsushita K, Abate KH et al (2017) Global cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol 28:2167–2179CrossRef
14.
go back to reference Fung CS, Wan EY, Chan AK, Lam CL (2017) Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus—a population-based retrospective cohort study. BMC Nephrol 18:47CrossRef Fung CS, Wan EY, Chan AK, Lam CL (2017) Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in Chinese patients with type 2 diabetes mellitus—a population-based retrospective cohort study. BMC Nephrol 18:47CrossRef
16.
go back to reference Fadini GP, Zatti G, Consoli A, Bonora E, Sesti G, Avogaro A (2017) Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): a multicenter retrospective nationwide Italian study and crowdsourcing opportunity. Nutr Metab Cardiovasc Dis 27:1089–1097CrossRef Fadini GP, Zatti G, Consoli A, Bonora E, Sesti G, Avogaro A (2017) Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): a multicenter retrospective nationwide Italian study and crowdsourcing opportunity. Nutr Metab Cardiovasc Dis 27:1089–1097CrossRef
17.
go back to reference Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
18.
go back to reference Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612CrossRef
20.
go back to reference Rubin R (1996) Multiple imputation after 18+ years. J Am Stat Assoc 91:473–489CrossRef Rubin R (1996) Multiple imputation after 18+ years. J Am Stat Assoc 91:473–489CrossRef
21.
go back to reference Penno G, Solini A, Zoppini G et al (2015) Hypertriglyceridemia Is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian Multicenter Study. PLoS One 10:e0125512CrossRef Penno G, Solini A, Zoppini G et al (2015) Hypertriglyceridemia Is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian Multicenter Study. PLoS One 10:e0125512CrossRef
22.
go back to reference Russo GT, De Cosmo S, Viazzi F et al (2016) Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care 39:2278–2287CrossRef Russo GT, De Cosmo S, Viazzi F et al (2016) Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care 39:2278–2287CrossRef
23.
go back to reference Tsuruya K, Yoshida H, Nagata M et al (2015) Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis 66:972–983CrossRef Tsuruya K, Yoshida H, Nagata M et al (2015) Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis 66:972–983CrossRef
24.
go back to reference Lanktree MB, Theriault S, Walsh M, Pare G (2018) HDL cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: a Mendelian randomization study. Am J Kidney Dis 71:166–172CrossRef Lanktree MB, Theriault S, Walsh M, Pare G (2018) HDL cholesterol, LDL cholesterol, and triglycerides as risk factors for CKD: a Mendelian randomization study. Am J Kidney Dis 71:166–172CrossRef
25.
go back to reference Scott D, Cumming R, Naganathan V et al (2018) Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: the concord health and ageing in men project. Exp Gerontol 108:99–105CrossRef Scott D, Cumming R, Naganathan V et al (2018) Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: the concord health and ageing in men project. Exp Gerontol 108:99–105CrossRef
26.
go back to reference Ferrara LA, Capaldo B, Mancusi C et al (2014) Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the strong heart study. Nutr Metab Cardiovasc Dis 24:271–276CrossRef Ferrara LA, Capaldo B, Mancusi C et al (2014) Cardiometabolic risk in overweight subjects with or without relative fat-free mass deficiency: the strong heart study. Nutr Metab Cardiovasc Dis 24:271–276CrossRef
27.
go back to reference Izquierdo-Lahuerta A, Martinez-Garcia C, Medina-Gomez G (2016) Lipotoxicity as a trigger factor of renal disease. J Nephrol 29:603–610CrossRef Izquierdo-Lahuerta A, Martinez-Garcia C, Medina-Gomez G (2016) Lipotoxicity as a trigger factor of renal disease. J Nephrol 29:603–610CrossRef
28.
go back to reference Karalliedde J, Gnudi L (2016) Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transpl 31:206–213 Karalliedde J, Gnudi L (2016) Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transpl 31:206–213
29.
go back to reference Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305CrossRef
30.
go back to reference Targher G, Byrne CD (2017) Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol 13:297–310CrossRef Targher G, Byrne CD (2017) Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol 13:297–310CrossRef
31.
go back to reference Hwang ST, Cho YK, Yun JW et al (2010) Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Intern Med J 40:437–442CrossRef Hwang ST, Cho YK, Yun JW et al (2010) Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. Intern Med J 40:437–442CrossRef
32.
go back to reference Avogaro A, Fadini GP (2014) The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. Diabetes Care 37:2884–2894CrossRef Avogaro A, Fadini GP (2014) The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. Diabetes Care 37:2884–2894CrossRef
33.
go back to reference Tella SH, Rendell MS (2015) DPP-4 inhibitors: focus on safety. Expert Opin Drug Saf 14:127–140CrossRef Tella SH, Rendell MS (2015) DPP-4 inhibitors: focus on safety. Expert Opin Drug Saf 14:127–140CrossRef
34.
go back to reference Russo GT, De Cosmo S, Viazzi F et al (2018) Diabetic kidney disease in the elderly: prevalence and clinical correlates. BMC Geriatr 18:38CrossRef Russo GT, De Cosmo S, Viazzi F et al (2018) Diabetic kidney disease in the elderly: prevalence and clinical correlates. BMC Geriatr 18:38CrossRef
35.
go back to reference Solini A, Penno G, Bonora E et al (2013) Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc 61:1253–1261CrossRef Solini A, Penno G, Bonora E et al (2013) Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. J Am Geriatr Soc 61:1253–1261CrossRef
36.
go back to reference Vinik A (2011) The question is, my dear watson, why did the dog not bark? The Joslin 50-year medalist study. Diabetes Care 34:1060–1063CrossRef Vinik A (2011) The question is, my dear watson, why did the dog not bark? The Joslin 50-year medalist study. Diabetes Care 34:1060–1063CrossRef
37.
go back to reference Qi W, Li Q, Gordin D, King GL (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373–381CrossRef Qi W, Li Q, Gordin D, King GL (2018) Preservation of renal function in chronic diabetes by enhancing glomerular glucose metabolism. J Mol Med (Berl) 96:373–381CrossRef
39.
go back to reference Pugliese G, Solini A, Fondelli C et al (2011) Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and cardiovascular events (RIACE) study. Nephrol Dial Transpl 26:3950–3954CrossRef Pugliese G, Solini A, Fondelli C et al (2011) Reproducibility of albuminuria in type 2 diabetic subjects. Findings from the renal insufficiency and cardiovascular events (RIACE) study. Nephrol Dial Transpl 26:3950–3954CrossRef
40.
go back to reference Penno G, Solini A, Bonora E et al (2018) Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian Multicenter Study. Acta Diabetol 55:603–612CrossRef Penno G, Solini A, Bonora E et al (2018) Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the renal insufficiency and cardiovascular events (RIACE) Italian Multicenter Study. Acta Diabetol 55:603–612CrossRef
Metadata
Title
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study
Authors
G P Fadini
A Solini
M L Manca
G Zatti
I Karamouzis
A Di Benedetto
L Frittitta
A Avogaro
For the DARWIN-T2D Network
Publication date
01-11-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 11/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1194-z

Other articles of this Issue 11/2018

Acta Diabetologica 11/2018 Go to the issue